Evidence map›Paper›PMID 39838663›Full record

ReviewCurrent pharmaceutical biotechnology2026

Dual Biological Effects and Mechanisms of Gut Microbiota in Breast Cancer: A Review.

Long Ma, Yuxin Liu, Mingliang Ning, Xiaoyun Ding, Chunyan Shang, Bin Mai, Zhiqiang Hu, Ru Zhou

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current pharmaceutical biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Long MaDepartment of Pharmacology, College of Pharmacy, Ningxia Medical University, Yinchuan, Ningxia, China.
Yuxin LiuDepartment of Pharmacology, College of Pharmacy, Ningxia Medical University, Yinchuan, Ningxia, China.
Mingliang NingOncology Hospital, General Hospital of Ningxia Medical University, 804 Shengli Street, 750004 Yinchua, Ningxia, China.
Xiaoyun DingOncology Hospital, General Hospital of Ningxia Medical University, 804 Shengli Street, 750004 Yinchua, Ningxia, China.
Chunyan ShangOncology Hospital, General Hospital of Ningxia Medical University, 804 Shengli Street, 750004 Yinchua, Ningxia, China.
Bin MaiOncology Hospital, General Hospital of Ningxia Medical University, 804 Shengli Street, 750004 Yinchua, Ningxia, China.
Zhiqiang HuOncology Hospital, General Hospital of Ningxia Medical University, 804 Shengli Street, 750004 Yinchua, Ningxia, China.
Ru ZhouDepartment of Pharmacology, College of Pharmacy, Ningxia Medical University, Yinchuan, Ningxia, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer (BC) is a common malignant tumor. BC is serious and has a high mortality rate. The incidence of BC has increased in recent years. The incidence rate is higher in coastal cities than in inland areas and in urban areas than in rural areas. Affect the occurrence and development of BC, such as inflammation and immune response. One of the cutting- edge studies to gain insight into the pathogenesis of BC is through the gut microbiota (GM) influencing the health status of the human body. Advances in metabolomics analysis can provide a clearer picture of changes in the composition of GM. The composition and quantity of GM can affect the health of other parts of the body, and the disorder of GM can lead to the occurrence and aggravation of diseases in different parts of the body. This paper not only discusses the dual biological effects of GM on BC, the relationship between GM and its metabolites, and BC and its related mechanisms but also explores traditional treatments for BC as well as the treatment of BC through GM, providing theoretical support for the use of methods to regulate GM in the clinical study of BC.

Indexed as

Breast NeoplasmsGastrointestinal MicrobiomeAnimalsFemaleHumansanticancerBreast cancercancer therapydual biological effectsgut microbiotamicrobiome

Identifiers

PMID39838663

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.